Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 5

COPD and cognitive impairment: the role of hypoxemia and oxygen therapy

Authors Neeta Thakur, Paul D Blanc, Laura J Julian, et al

Published 10 August 2010 Volume 2010:5 Pages 263—269


Review by Single-blind

Peer reviewer comments 3

Neeta Thakur1, Paul D Blanc2, Laura J Julian1, Edward H Yelin3, Patricia P Katz3, Stephen Sidney4, Carlos Iribarren4, Mark D Eisner1,2

1Department of Medicine, 2Division of Occupational and Environmental Medicine and Division of Pulmonary and Critical Care Medicine, 3Institute for Health Policy Studies, Department of Medicine, University of California, San Francisco, CA, USA, 4Division of Research, Kaiser Permanente, Oakland, CA, USA

Background: Several studies have shown an association between chronic obstructive pulmonary disease (COPD) and cognitive impairment. These studies have been limited by methodological issues such as diagnostic uncertainty, cross-sectional design, small sample size, or lack of appropriate referent group. This study aimed to elucidate the association between COPD and the risk of cognitive impairment compared to referent subjects without COPD. In patients with established COPD, we evaluated the impact of disease severity and impairment of respiratory physiology on cognitive impairment and the potential mitigating role of oxygen therapy.

Methods: We used the Function, Living, Outcomes and Work (FLOW) cohort study of adults with COPD (n = 1202) and referent subjects matched by age, sex, and race (n = 302) to study the potential risk factors for cognitive impairment among subjects with COPD. Cognitive impairment was defined as a Mini-Mental State Exam score of <24 points. Disease severity was using Forced Expiratory Volume in one second (FEV1); the validated COPD Severity Score; and the BMI (Body Mass Index), Obstruction, Dyspnea, Exercise Capacity (BODE) Index. Multivariable analysis was used to control for confounding by age, sex, race, educational attainment, and cigarette smoking.

Results: COPD was associated with a substantive risk of cognitive impairment compared to referent subjects (odds ratio [OR] 2.42; 95% confidence interval [CI] 1.043–6.64). Among COPD patients, none of the COPD severity measures were associated with the risk of cognitive impairment (P > 0.20 in all cases). Low baseline oxygen saturation was related to increased risk of cognitive impairment (OR for oxygen saturation ≤ 88% (OR 5.45; 95% CI 1.014–29.2; P = 0.048). Conversely, regular use of supplemental oxygen therapy decreased the risk for cognitive impairment (OR 0.14; 95% CI 0.07–0.27; P < 0.0001).

Conclusion: COPD is a major risk factor for cognitive impairment. Among patients with COPD, hypoxemia is a major contributor and regular use of home oxygen is protective. Health care providers should consider screening their COPD patients for cognitive impairment.

Keywords: chronic obstructive pulmonary disease

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Other article by this author:

The impact of SHS exposure on health status and exacerbations among patients with COPD

Mark D Eisner, Carlos Iribarren, Edward H Yelin, Stephen Sidney, et al.

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:169-176

Published Date: 6 May 2009

Readers of this article also read:

p27Kip1 and Ser10-phosphorylated p27Kip1 in breast cancer: clinical significance and expression

Song W, Xie RL, Zhu AY, Xu YM, Shi YQ, Shen Y, Zhang WW, Yang F, Guan XX

OncoTargets and Therapy 2015, 8:1863-1869

Published Date: 24 July 2015

Self-reported alcohol intake and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study

Wetherbee EE, Niewoehner DE, Sisson JH, Lindberg SM, Connett JE, Kunisaki KM

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1363-1370

Published Date: 20 July 2015

Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects

Besa V, Teschler H, Kurth I, Khan AM, Zarogoulidis P, Baumbach JI, Sommerwerck U, Freitag L, Darwiche K

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:399-406

Published Date: 23 February 2015

Coexistence of anxiety sensitivity and psychiatric comorbidities in patients with chronic tinnitus

Gül Aİ, Özkırış M, Aydın R, Şimşek G, Saydam L

Neuropsychiatric Disease and Treatment 2015, 11:413-418

Published Date: 19 February 2015

A living thick nanofibrous implant bifunctionalized with active growth factor and stem cells for bone regeneration

Eap S, Keller L, Schiavi J, Huck O, Jacomine L, Fioretti F, Gauthier C, Sebastian V, Schwinté P, Benkirane-Jessel N

International Journal of Nanomedicine 2015, 10:1061-1075

Published Date: 4 February 2015

PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway

Bao W, Liu R, Wang YL, Wang F, Xia GH, Zhang HJ, Li XM, Yin HX, Chen BA

International Journal of Nanomedicine 2015, 10:557-566

Published Date: 12 January 2015

Whole-body vibration improves functional capacity and quality of life in patients with severe chronic obstructive pulmonary disease (COPD): a pilot study

Braz Júnior DS, Dornelas de Andrade A, Teixeira AS, Cavalcanti CA, Morais AB, Marinho PE

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:125-132

Published Date: 12 January 2015

The use of endoillumination probe-assisted Descemet membrane endothelial keratoplasty for bullous keratopathy secondary to argon laser iridotomy

Kobayashi A, Yokogawa H, Yamazaki N, Masaki T, Sugiyama K

Clinical Ophthalmology 2015, 9:91-93

Published Date: 8 January 2015

Photo activation of HPPH encapsulated in “Pocket” liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenografts

Sine J, Urban C, Thayer D, Charron H, Valim N, Tata DB, Schiff R, Blumenthal R, Joshi A, Puri A

International Journal of Nanomedicine 2015, 10:125-145

Published Date: 19 December 2014